Software Healthcare Sector

Spectral Medical

Market Cap: CA$393.4m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

Treace Medical Concepts

Market Cap: US$282.2m

A medical technology company, designs, manufactures, and markets medical devices in the United States.

ALX Oncology Holdings

Market Cap: US$282.1m

A clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States.

Surrozen

Market Cap: US$282.0m

A biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair.

Turn Therapeutics

Market Cap: US$281.8m

Operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye.

Camp4 Therapeutics

Market Cap: US$281.1m

A clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases.

Biodesix

Market Cap: US$281.0m

Operates as a diagnostic solutions company.

Eledon Pharmaceuticals

Market Cap: US$280.6m

Operates as a clinical stage biotechnology company.

Fate Therapeutics

Market Cap: US$279.2m

A clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally.

Tristel

Market Cap: UK£203.9m

Develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally.

AFT Pharmaceuticals

Market Cap: NZ$463.5m

Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.

Lineage Cell Therapeutics

Market Cap: US$273.1m

A clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally.

Entrada Therapeutics

Market Cap: US$273.0m

A clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible.

Adagene

Market Cap: US$269.9m

A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.

Whitehawk Therapeutics

Market Cap: US$269.7m

A clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments.

OraSure Technologies

Market Cap: US$267.6m

Develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally.

Alector

Market Cap: US$263.5m

A clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States.

Standard BioTools

Market Cap: US$262.6m

Develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific.

MacroGenics

Market Cap: US$261.2m

A clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States.

Emergent BioSolutions

Market Cap: US$260.5m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally.

Cipher Pharmaceuticals

Market Cap: CA$358.4m

Operates as a specialty pharmaceutical company in Canada.

RxSight

Market Cap: US$260.0m

A commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States.

Pyxis Oncology

Market Cap: US$256.9m

A clinical stage company, engages in the development of therapeutics to treat solid tumors.

Aurora Cannabis

Market Cap: CA$350.9m

Engages in the production, distribution, and sale of cannabis products in Canada and internationally.

Sol-Gel Technologies

Market Cap: US$254.1m

Together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally.

Akebia Therapeutics

Market Cap: US$251.2m

A biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.

Starpharma Holdings

Market Cap: AU$348.3m

A biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally.

Compugen

Market Cap: US$247.7m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Profound Medical

Market Cap: CA$340.5m

Operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue.

Greenwich LifeSciences

Market Cap: US$244.7m

A clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States.

Precision BioSciences

Market Cap: US$244.3m

A clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States.

InfuSystem Holdings

Market Cap: US$243.2m

Through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada.

Sionna Therapeutics

Market Cap: US$239.2m

A clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).

Conexeu Sciences

Market Cap: US$237.9m

Develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair.

Healius

Market Cap: AU$330.4m

Provides medical laboratory and pathology services in Australia.

Auxly Cannabis Group

Market Cap: CA$325.2m

Operates as a consumer-packaged goods company in the cannabis products market in Canada.